SIO CAPITAL MANAGEMENT, LLC Holdings

SIO CAPITAL MANAGEMENT, LLC is an investment fund managing more than 314.71M US dollars. The largest holdings include AmerisourceBergen, Apellis Pharmaceuticals and GSK. In Q3 2022 the fund bought assets of total value of 56.82M US dollars and sold assets of total value of 68.76M US dollars.

$314.70M

portfolio value

-0.74%

quarter

-22.12%

1 year

+55.25%

3 years

+105.34%

5 years

SIO CAPITAL MANAGEMENT, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2016	100671000	79309000
Q2 2016	43099000	117998000
Q3 2016	31570000	59363000
Q4 2016	34003000	42060000
Q1 2017	65642000	32332000
Q2 2017	41435000	40840000
Q3 2017	51230000	63751000
Q4 2017	44726000	60388000
Q1 2018	102588000	51111000
Q2 2018	85376000	76084000
Q3 2018	118782000	45785000
Q4 2018	131039000	97170000
Q1 2019	156000000	88677000
Q2 2019	119693000	140921000
Q3 2019	90863000	145455000
Q4 2019	129794000	86972000
Q1 2020	140220000	157466000
Q2 2020	151750000	103202000
Q3 2020	219940000	89916000
Q4 2020	138446000	130212000
Q1 2021	138168000	119168000
Q2 2021	65482000	171804000
Q3 2021	46527000	94577000
Q4 2021	120160000	74053000
Q1 2022	59508000	130879000
Q2 2022	120428000	107242000
Q3 2022	56816000	68761000

SIO CAPITAL MANAGEMENT, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Medical Distribution AmerisourceBergen Corporation Portfolio share: 12.14% Portfolio value: 38.21M Avg. open price: $122.9 Current price: $171.25 P/L: +39.34% Bought +54.04% shares Q3 2022	share	12.14%	38.21M	$122.9	$171.25	+39.34%	Bought +54.04% shares Q3 2022
Biotechnology Apellis Pharmaceuticals, Inc. Portfolio share: 11.02% Portfolio value: 34.67M Avg. open price: N/A Current price: $49.41 P/L: N/A N/A Q3 2022	put	11.02%	34.67M	N/A	$49.41	N/A	N/A Q3 2022
Drug Manufacturers—General GSK plc Portfolio share: 7.39% Portfolio value: 23.26M Avg. open price: $33.18 Current price: $35.16 P/L: +5.95% N/A Q3 2022	share	7.39%	23.26M	$33.18	$35.16	+5.95%	N/A Q3 2022
Shell Companies Medicus Sciences Acquisition Corp. Portfolio share: 7.31% Portfolio value: 22.99M Avg. open price: N/A Current price: $10 P/L: N/A N/A Q4 2021	share	7.31%	22.99M	N/A	$10	N/A	N/A Q4 2021
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 7.13% Portfolio value: 22.44M Avg. open price: N/A Current price: $4.45 P/L: N/A N/A Q3 2022	put	7.13%	22.44M	N/A	$4.45	N/A	N/A Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 6.23% Portfolio value: 19.60M Avg. open price: $28.23 Current price: $37.72 P/L: +33.62% Bought +226.97% shares Q3 2022	put	6.23%	19.60M	$28.23	$37.72	+33.62%	Bought +226.97% shares Q3 2022
Biotechnology Bicycle Therapeutics plc Portfolio share: 5.05% Portfolio value: 15.89M Avg. open price: $43.88 Current price: $32.41 P/L: -26.14% Sold -0.81% shares Q3 2022	share	5.05%	15.89M	$43.88	$32.41	-26.14%	Sold -0.81% shares Q3 2022
Drug Manufacturers—General Organon & Co. Portfolio share: 4.68% Portfolio value: 14.71M Avg. open price: $33.75 Current price: $26.35 P/L: -21.93% Bought +9.39% shares Q3 2022	share	4.68%	14.71M	$33.75	$26.35	-21.93%	Bought +9.39% shares Q3 2022
Healthcare Plans CIGNA CORP Portfolio share: 4.64% Portfolio value: 14.59M Avg. open price: $209.44 Current price: $327.39 P/L: +56.32% Sold -0.80% shares Q3 2022	share	4.64%	14.59M	$209.44	$327.39	+56.32%	Sold -0.80% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 4.31% Portfolio value: 13.56M Avg. open price: $44.44 Current price: $44.93 P/L: +1.10% N/A Q3 2022	share	4.31%	13.56M	$44.44	$44.93	+1.10%	N/A Q3 2022
Medical Devices Inogen, Inc. Portfolio share: 4.02% Portfolio value: 12.65M Avg. open price: $33.61 Current price: $21.4 P/L: -36.33% Sold -0.79% shares Q3 2022	share	4.02%	12.65M	$33.61	$21.4	-36.33%	Sold -0.79% shares Q3 2022
Healthcare Plans Centene Corporation Portfolio share: 3.14% Portfolio value: 9.88M Avg. open price: $79.43 Current price: $86.35 P/L: +8.71% Sold -1.55% shares Q3 2022	share	3.14%	9.88M	$79.43	$86.35	+8.71%	Sold -1.55% shares Q3 2022
Biotechnology United Therapeutics Corporation Portfolio share: 2.99% Portfolio value: 9.41M Avg. open price: $119.16 Current price: $273.72 P/L: +129.71% Bought +12.51% shares Q3 2022	share	2.99%	9.41M	$119.16	$273.72	+129.71%	Bought +12.51% shares Q3 2022
Household & Personal Products The Beauty Health Company Portfolio share: 2.47% Portfolio value: 7.76M Avg. open price: $12.86 Current price: $11.03 P/L: -14.23% Bought +81.89% shares Q3 2022	share	2.47%	7.76M	$12.86	$11.03	-14.23%	Bought +81.89% shares Q3 2022
Medical Devices Smith & Nephew plc Portfolio share: 1.69% Portfolio value: 5.30M Avg. open price: $35.26 Current price: $26.77 P/L: -24.08% N/A Q3 2022	share	1.69%	5.30M	$35.26	$26.77	-24.08%	N/A Q3 2022
Biotechnology Vanda Pharmaceuticals Inc. Portfolio share: 1.54% Portfolio value: 4.83M Avg. open price: $11.33 Current price: $10.61 P/L: -6.37% Bought +200.94% shares Q2 2022	share	1.54%	4.83M	$11.33	$10.61	-6.37%	Bought +200.94% shares Q2 2022
Biotechnology POINT Biopharma Global Inc. Portfolio share: 1.34% Portfolio value: 4.20M Avg. open price: $7.69 Current price: $6.72 P/L: -12.64% Bought +7.93% shares Q3 2022	share	1.34%	4.20M	$7.69	$6.72	-12.64%	Bought +7.93% shares Q3 2022
Medical Devices Inari Medical, Inc. Portfolio share: 1.33% Portfolio value: 4.17M Avg. open price: $90.64 Current price: $71.11 P/L: -21.55% Sold -48.90% shares Q3 2022	share	1.33%	4.17M	$90.64	$71.11	-21.55%	Sold -48.90% shares Q3 2022
Medical Care Facilities Universal Health Services, Inc. Portfolio share: 1.14% Portfolio value: 3.59M Avg. open price: $138.7 Current price: $127.36 P/L: -8.18% N/A Q2 2022	share	1.14%	3.59M	$138.7	$127.36	-8.18%	N/A Q2 2022
Shell Companies Eucrates Biomedical Acquisition Corp. Portfolio share: 0.79% Portfolio value: 2.49M Avg. open price: N/A Current price: $10.04 P/L: N/A Sold -17.11% shares Q3 2021	share	0.79%	2.49M	N/A	$10.04	N/A	Sold -17.11% shares Q3 2021
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.79% Portfolio value: 2.47M Avg. open price: N/A Current price: $9.96 P/L: N/A N/A Q3 2020	share	0.79%	2.47M	N/A	$9.96	N/A	N/A Q3 2020
Biotechnology Aeglea BioTherapeutics, Inc. Portfolio share: 0.78% Portfolio value: 2.45M Avg. open price: $2.89 Current price: $0.47 P/L: -83.74% Bought +435.94% shares Q2 2022	share	0.78%	2.45M	$2.89	$0.47	-83.74%	Bought +435.94% shares Q2 2022
Biotechnology X4 Pharmaceuticals, Inc. Portfolio share: 0.77% Portfolio value: 2.42M Avg. open price: $0.97 Current price: $1.29 P/L: +33.68% Bought +412.25% shares Q3 2022	share	0.77%	2.42M	$0.97	$1.29	+33.68%	Bought +412.25% shares Q3 2022
Medical Devices Modular Medical, Inc. Portfolio share: 0.75% Portfolio value: 2.36M Avg. open price: N/A Current price: $3.01 P/L: N/A N/A Q2 2022	share	0.75%	2.36M	N/A	$3.01	N/A	N/A Q2 2022
Biotechnology CymaBay Therapeutics, Inc. Portfolio share: 0.62% Portfolio value: 1.94M Avg. open price: $1.63 Current price: $4.17 P/L: +155.65% Sold -1.20% shares Q2 2022	share	0.62%	1.94M	$1.63	$4.17	+155.65%	Sold -1.20% shares Q2 2022
Drug Manufacturers—Specialty & Generic Bausch Health Companies Inc. Portfolio share: 0.62% Portfolio value: 1.93M Avg. open price: $22.85 Current price: $7.55 P/L: -66.96% Sold -73.03% shares Q3 2022	put	0.62%	1.93M	$22.85	$7.55	-66.96%	Sold -73.03% shares Q3 2022
Biotechnology Renovacor, Inc. Portfolio share: 0.59% Portfolio value: 1.85M Avg. open price: N/A Current price: $3.2 P/L: N/A Sold -0.06% shares Q4 2021	share	0.59%	1.85M	N/A	$3.2	N/A	Sold -0.06% shares Q4 2021
Biotechnology Merus N.V. Portfolio share: 0.56% Portfolio value: 1.76M Avg. open price: N/A Current price: $14.2 P/L: N/A Sold -2.27% shares Q2 2022	share	0.56%	1.76M	N/A	$14.2	N/A	Sold -2.27% shares Q2 2022
Biotechnology Affimed N.V. Portfolio share: 0.54% Portfolio value: 1.69M Avg. open price: $5.38 Current price: $2.12 P/L: -60.70% Bought +27.56% shares Q2 2022	share	0.54%	1.69M	$5.38	$2.12	-60.70%	Bought +27.56% shares Q2 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.49% Portfolio value: 1.55M Avg. open price: N/A Current price: $21.89 P/L: N/A N/A Q2 2022	put	0.49%	1.55M	N/A	$21.89	N/A	N/A Q2 2022
Biotechnology Tyra Biosciences, Inc. Portfolio share: 0.42% Portfolio value: 1.33M Avg. open price: $10.7 Current price: $6.89 P/L: -35.61% Bought +37.04% shares Q2 2022	share	0.42%	1.33M	$10.7	$6.89	-35.61%	Bought +37.04% shares Q2 2022
Biotechnology Savara Inc. Portfolio share: 0.42% Portfolio value: 1.32M Avg. open price: $1.31 Current price: $1.64 P/L: +25.49% Bought +19.57% shares Q2 2022	share	0.42%	1.32M	$1.31	$1.64	+25.49%	Bought +19.57% shares Q2 2022
Drug Manufacturers—Specialty & Generic ANI Pharmaceuticals, Inc. Portfolio share: 0.41% Portfolio value: 1.28M Avg. open price: N/A Current price: $37.98 P/L: N/A N/A Q4 2021	share	0.41%	1.28M	N/A	$37.98	N/A	N/A Q4 2021
Biotechnology Moleculin Biotech, Inc. Portfolio share: 0.35% Portfolio value: 1.09M Avg. open price: $3.89 Current price: $1.32 P/L: -66.08% Sold -0.35% shares Q2 2022	share	0.35%	1.09M	$3.89	$1.32	-66.08%	Sold -0.35% shares Q2 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 0.33% Portfolio value: 1.04M Avg. open price: N/A Current price: $17.77 P/L: N/A N/A Q3 2022	share	0.33%	1.04M	N/A	$17.77	N/A	N/A Q3 2022
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 0.25% Portfolio value: 784K Avg. open price: $11.54 Current price: $2.36 P/L: -79.55% Bought +0.26% shares Q2 2022	share	0.25%	784K	$11.54	$2.36	-79.55%	Bought +0.26% shares Q2 2022
Biotechnology Connect Biopharma Holdings Limited Portfolio share: 0.24% Portfolio value: 771K Avg. open price: N/A Current price: $0.71 P/L: N/A N/A Q1 2022	share	0.24%	771K	N/A	$0.71	N/A	N/A Q1 2022
Biotechnology ASLAN Pharmaceuticals Limited Portfolio share: 0.24% Portfolio value: 761K Avg. open price: $1.94 Current price: $0.53 P/L: -72.52% Sold -14.63% shares Q3 2021	share	0.24%	761K	$1.94	$0.53	-72.52%	Sold -14.63% shares Q3 2021
Biotechnology Elevation Oncology, Inc. Portfolio share: 0.13% Portfolio value: 406K Avg. open price: $5.76 Current price: $0.95 P/L: -83.51% Bought +43.89% shares Q1 2022	share	0.13%	406K	$5.76	$0.95	-83.51%	Bought +43.89% shares Q1 2022
Biotechnology NextCure, Inc. Portfolio share: 0.11% Portfolio value: 358K Avg. open price: N/A Current price: $1.4 P/L: N/A N/A Q4 2021	share	0.11%	358K	N/A	$1.4	N/A	N/A Q4 2021
Health Information Services CareMax, Inc. Portfolio share: 0.07% Portfolio value: 218K Avg. open price: N/A Current price: $3.49 P/L: N/A Sold -29.41% shares Q3 2021	share	0.07%	218K	N/A	$3.49	N/A	Sold -29.41% shares Q3 2021
Biotechnology Vincerx Pharma, Inc. Portfolio share: 0.04% Portfolio value: 141K Avg. open price: $19.3 Current price: $0.7 P/L: -96.37% Sold -27.58% shares Q3 2021	share	0.04%	141K	$19.3	$0.7	-96.37%	Sold -27.58% shares Q3 2021
Biotechnology NeuBase Therapeutics, Inc. Portfolio share: 0.03% Portfolio value: 102K Avg. open price: $7.44 Current price: $0.23 P/L: -96.95% Sold -71.38% shares Q3 2022	share	0.03%	102K	$7.44	$0.23	-96.95%	Sold -71.38% shares Q3 2022
NYXOAH SA Portfolio share: 0.03% Portfolio value: 101K Avg. open price: N/A Current price: N/A P/L: N/A Sold -1.23% shares Q4 2021	share	0.03%	101K	N/A	N/A	N/A	Sold -1.23% shares Q4 2021
Biotechnology Clene Inc. Portfolio share: 0.02% Portfolio value: 64K Avg. open price: N/A Current price: $1.09 P/L: N/A N/A Q3 2022	put	0.02%	64K	N/A	$1.09	N/A	N/A Q3 2022
HUMACYTE INC Portfolio share: 0.02% Portfolio value: 58K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	58K	N/A	N/A	N/A	N/A Q3 2021
RENOVACOR INC Portfolio share: 0.01% Portfolio value: 37K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	37K	N/A	N/A	N/A	N/A Q3 2021
Drug Manufacturers—Specialty & Generic Neoleukin Therapeutics, Inc. Portfolio share: 0.01% Portfolio value: 25K Avg. open price: N/A Current price: $0.43 P/L: N/A Sold -56.55% shares Q2 2020	share	0.01%	25K	N/A	$0.43	N/A	Sold -56.55% shares Q2 2020
CAREMAX INC Portfolio share: 0.01% Portfolio value: 23K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	23K	N/A	N/A	N/A	N/A Q3 2021
Medical Care Facilities HCA Healthcare, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $110.95 Current price: $235.35 P/L: +112.12% Sold -100.00% shares Q3 2022	share	0.00%	0	$110.95	$235.35	+112.12%	Sold -100.00% shares Q3 2022
Medical Care Facilities Tenet Healthcare Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $44.6 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$44.6	N/A	Sold -100.00% shares Q3 2022
Biotechnology Cyclacel Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.49 Current price: $0.77 P/L: -77.93% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.49	$0.77	-77.93%	Sold -100.00% shares Q3 2022
Medical Devices Heska Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $66.42 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$66.42	N/A	Sold -100.00% shares Q3 2022
Biotechnology Inhibrx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $22.28 Current price: $29.18 P/L: +30.97% Sold -100.00% shares Q3 2022	share	0.00%	0	$22.28	$29.18	+30.97%	Sold -100.00% shares Q3 2022
Biotechnology Precision BioSciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.33 Current price: $1.24 P/L: -85.12% Sold -100.00% shares Q3 2022	share	0.00%	0	$8.33	$1.24	-85.12%	Sold -100.00% shares Q3 2022
Biotechnology Viking Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.37 Current price: $3.97 P/L: -52.54% Sold -100.00% shares Q3 2022	share	0.00%	0	$8.37	$3.97	-52.54%	Sold -100.00% shares Q3 2022
Medical Devices IsoPlexis Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.29 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.29	N/A	Sold -100.00% shares Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $38.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$38.83	N/A	Sold -100.00% shares Q3 2022
Medical Distribution Cardinal Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $51.52 Current price: $79.48 P/L: +54.28% Sold -100.00% shares Q3 2022	share	0.00%	0	$51.52	$79.48	+54.28%	Sold -100.00% shares Q3 2022
Biotechnology Pardes Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $17.02 Current price: $1.1 P/L: -93.54% Sold -100.00% shares Q3 2022	share	0.00%	0	$17.02	$1.1	-93.54%	Sold -100.00% shares Q3 2022
Biotechnology Biohaven Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $16.32 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$16.32	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $292.75 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$292.75	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Bausch Health Companies Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $22.85 Current price: $7.55 P/L: -66.96% Sold -100.00% shares Q3 2022	share	0.00%	0	$22.85	$7.55	-66.96%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $92.04 Current price: $98.48 P/L: +7.00% Sold -100.00% shares Q3 2022	share	0.00%	0	$92.04	$98.48	+7.00%	Sold -100.00% shares Q3 2022
Medical Devices Medtronic plc Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $94.79 Current price: $78.79 P/L: -16.88% Sold -100.00% shares Q3 2022	share	0.00%	0	$94.79	$78.79	-16.88%	Sold -100.00% shares Q3 2022
Medical Devices Natus Medical Incorporated Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $24.13 Current price: $32.96 P/L: +36.61% Sold -100.00% shares Q3 2022	share	0.00%	0	$24.13	$32.96	+36.61%	Sold -100.00% shares Q3 2022
Biotechnology Ardelyx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.32 Current price: $1.86 P/L: -43.97% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.32	$1.86	-43.97%	Sold -100.00% shares Q3 2022
Medical Devices Sight Sciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.71 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$11.71	N/A	Sold -100.00% shares Q3 2022
Biotechnology Albireo Pharma, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $31.2 Current price: $22.7 P/L: -27.24% Sold -100.00% shares Q3 2022	share	0.00%	0	$31.2	$22.7	-27.24%	Sold -100.00% shares Q3 2022

Showing TOP 69 SIO CAPITAL MANAGEMENT's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of SIO CAPITAL MANAGEMENT, LLC?

The biggest position of the SIO CAPITAL MANAGEMENT, LLC is AmerisourceBergen Corporation (ABC) with 12.14% portfolio share worth of 38.22M US dollars.

Top 5 SIO CAPITAL MANAGEMENT's holdings represent 44.99% of the portfolio:

AmerisourceBergen Corporation (ABC) – 12.14%
Apellis Pharmaceuticals, Inc. (APLS) – 11.02%
GSK plc (GSK) – 7.39%
Medicus Sciences Acquisition Corp. (MSAC) – 7.31%
Relmada Therapeutics, Inc. (RLMD) – 7.13%

Who is the portfolio manager of SIO CAPITAL MANAGEMENT, LLC?

The portfolio manager of the SIO CAPITAL MANAGEMENT, LLC is .

What is the total asset value of the SIO CAPITAL MANAGEMENT, LLC portfolio?

SIO CAPITAL MANAGEMENT, LLC total asset value (portfolio value) is 314.71M US dollars.

Who is ?

is the portfolio manager of the SIO CAPITAL MANAGEMENT, LLC.

What is (SIO CAPITAL MANAGEMENT, LLC) fund performance?

SIO CAPITAL MANAGEMENT's quarterly performance is -0.74%, annualy -22.12%. In the past 3 years, the value of 's portfolio has increased by +55%. In the past 5 years, the value of the portfolio has increased by +105%.

What is the SIO CAPITAL MANAGEMENT, LLC CIK?

SIO CAPITAL MANAGEMENT's Central Index Key is 0001482416 .

SIO CAPITAL MANAGEMENT, LLC Holdings

SIO CAPITAL MANAGEMENT, LLC portfolio value:

SIO CAPITAL MANAGEMENT, LLC quarter portfolio value change:

SIO CAPITAL MANAGEMENT, LLC 1 year portfolio value change:

SIO CAPITAL MANAGEMENT, LLC 3 years portfolio value change:

SIO CAPITAL MANAGEMENT, LLC 5 years portfolio value change: